Cardiovasc Toxicol. 2026 Jan 27;26(2):21. doi: 10.1007/s12012-026-10094-y.
ABSTRACT
Copper ions are essential metal ions that play a pivotal role in various biochemical processes. Recent studies have identified a novel copper-dependent form of cell death named cuproptosis, which differs significantly from other well-characterized modes of cell death, such as apoptosis, pyroptosis, necrosis and ferroptosis. Moreover, a series of researches indicate that cuproptosis may be related to the occurrence and aggravation of cardiovascular diseases (CVDs). This review aims to elucidate the molecular mechanisms underlying cuproptosis and to summarize the pathways through which cuproptosis contributes to the pathogenesis of various cardiovascular conditions, including atherosclerosis, heart failure, dilated cardiomyopathy, atrial fibrillation, myocardial ischemia/reperfusion injury, diabetic cardiomyopathy, acute myocardial infarction, and vascular aging. Additionally, we explore therapeutic approaches involving copper chelators, small-molecule inhibitors targeting copper chaperone proteins, and copper ionophores, which may mitigate these cardiovascular disorders by inhibiting cuproptosis. Collectively, effective suppression of cuproptosis may become a novel therapeutic strategy for the prevention and treatment of related CVDs.
PMID:41591695 | DOI:10.1007/s12012-026-10094-y